Blog

In honor of their 30th anniversary, the UK-based FORCE Cancer Charity helped fund the Royal Devon and Exeter (RD&E) Hospital’s purchase of a PINPOINT Endoscopic Fluorescence Imaging System. FORCE, a charity that believes anyone affected by cancer deserves the best possible treatment, donated the system with the intent to help surgeons save lives, reduce unnecessary … Continue reading “FORCE Celebrates 30th Anniversary with Major New Equipment Purchase”

Toronto, Ontario – June 19, 2017 – NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ) (“NOVADAQ” or the “Corporation”), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it has entered into a definitive arrangement (the “Arrangement Agreement”) with Stryker Corporation … Continue reading “NOVADAQ ENTERS INTO AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION”

Toronto, Ontario – May 3, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries today reported financial results for the three months ended March 31, 2017. Unless otherwise indicated, all dollar amounts in this … Continue reading “NOVADAQ ANNOUNCES FIRST QUARTER 2017 FINANCIAL RESULTS”

Toronto, Ontario – April 19, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it will release financial results for the first quarter of 2017 after the close of trading on … Continue reading “NOVADAQ to Report First Quarter 2017 Financial Results on May 3, 2017”

Toronto, Ontario – February 28, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries today reported financial results for the three months and full year ended December 31, 2016. Unless otherwise indicated, all dollar … Continue reading “NOVADAQ Announces Fourth Quarter and Full Year 2016 Financial Results”

DermACELL receives coverage from Cigna

Posted on February 2, 2017

LifeNet Health is proud that Cigna Health Insurance is now covering Dermacell when used in association with covered medically necessary breast reconstruction procedures. Dermacell AWM has also been approved for coverage as medically necessary for diabetic foot ulcers when the following criteria are met: partial- or full-thickness diabetic foot ulcers of greater than four weeks … Continue reading “DermACELL receives coverage from Cigna”

Toronto, Ontario – February 15, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it will release financial results for the fourth quarter and full year 2016 after the close of … Continue reading “NOVADAQ TO REPORT FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS ON FEBRUARY 28, 2017”

Toronto, Ontario – February 8, 2017 – NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it plans to participate in two upcoming investor conferences. Rick Mangat, President and Chief Executive Officer, is … Continue reading “NOVADAQ ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES”

Secures up to $60 million in financing from Midcap Financial Toronto, Ontario – January 10, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced preliminary financial results for fourth quarter and full year 2016 … Continue reading “NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue and Issues 2017 Revenue guidance”

Toronto, Ontario – January 4, 2017 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Lisa Colleran has been appointed to its board of directors, effective immediately. Lisa Colleran is a veteran in … Continue reading “NOVADAQ appoints Lisa Colleran to its board of directors”